# Assessment of Pharmacokinetics (PK) and Safety of M834 and Orencia ®, in Healthy Subjects

> **NCT02923583** · PHASE1 · COMPLETED · sponsor: **Momenta Pharmaceuticals, Inc.** · enrollment: 243 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **BIOLOGICAL:** M834
- **BIOLOGICAL:** US-Sourced Orencia®
- **BIOLOGICAL:** EU-Sourced Orencia®

## Key facts

- **NCT ID:** NCT02923583
- **Lead sponsor:** Momenta Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10
- **Primary completion:** 2017-07-21
- **Final completion:** 2017-07-21
- **Target enrollment:** 243 (ACTUAL)
- **Last updated:** 2017-10-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02923583

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02923583, "Assessment of Pharmacokinetics (PK) and Safety of M834 and Orencia ®, in Healthy Subjects". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02923583. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*